Publication | Closed Access

The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus

InflammationMetabolic Syndromeα-Glucosidase Inhibitor MiglitolMedicineDiabetesImmunologyType 2Diabetes ComplicationsImmune FunctionDiabetes MellitusGlucose FluctuationsPharmacologyInsulin Signaling